journal article·2015Open access

Carbon nanotubes for stabilization of nanostructured lipid particles

Nicholas P. Gaunt, Yogita Patil-Sen, Matthew J. Baker, Chandrashekhar V. Kulkarni

Nanoscale· Volume 7· Issue 3

Abstract

Carbon nanotubes (CNTs) are increasingly studied for innovative biotechnological applications particularly where they are combined with essential biological materials like lipids. Lipids have been used earlier for enhancing the dispersibility of CNTs in aqueous solutions. Here we report a novel application of CNTs for stabilization of internally self-assembled nanostructured lipid particles of 2-5 μm size. Single-walled (pristine) as well as -OH and -COOH functionalized multi-walled CNTs were employed to produce nanostructured emulsions which stayed stable for months and could be re-dispersed after complete dehydration. Concentrations of CNTs employed for stabilization were very low; moreover CNTs were well-decorated with lipid molecules. These features contribute towards reducing their toxicity and improving biocompatibility for biomedical and pharmaceutical applications. Our approach paves the way for future development of combination therapies employing both CNTs and nanostructured lipid self-assembly together as carriers of different drugs.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Lipid Membrane Structure and Behavior · Nanopore and Nanochannel Transport Studies · Carbon Nanotubes in Composites

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Centre for Materials Science

School of Forensic and Investigative Sciences

University of Central Lancashire

Preston PR1 2HE, UK

WestCHEM

References (44)

Show source-provided references
1. W. Shao , P.Arghya , M.Yiyong , L.Rodes and S.Prakash , Carbon Nanotubes for Use in Medicine: Potentials and Limitations , 2013
2. He · Bio. Med. Res. Int. · 2013 · 2013 · 12
3. Gulati · Crit. Rev. Ther. Drug · 2012 · 29 · 6510.1615/CritRevTherDrugCarrierSyst.v29.i1.20 ↗
4. Prato · Acc. Chem. Res. · 2008 · 41 · 6010.1021/ar700089b ↗
5. Yang · Nanotechnology · 2007 · 18 · 41200110.1088/0957-4484/18/41/412001 ↗
6. Foldvari · Nanomedicine: Nanotechnology, Biology and Medicine · 2008 · 4 · 18310.1016/j.nano.2008.04.003 ↗
7. Foldvari · Nanomedicine: Nanotechnology, Biology and Medicine · 2008 · 4 · 17310.1016/j.nano.2008.04.002 ↗
8. Firme Iii · Nanomedicine: Nanotechnology, Biology and Medicine · 2010 · 6 · 24510.1016/j.nano.2009.07.003 ↗
9. Kam · Proc. Natl. Acad. Sci. U. S. A. · 2005 · 102 · 1160010.1073/pnas.0502680102 ↗
10. Richard · Science · 2003 · 300 · 77510.1126/science.1080848 ↗
11. Ashley · Nat. Mater. · 2011 · 10 · 38910.1038/nmat2992 ↗
12. Saito · Chem. Rev. · 2014 · 114 · 604010.1021/cr400341h ↗
13. Wu · J. Phys. Chem. B · 2006 · 110 · 247510.1021/jp057252c ↗
14. Liu · J. Nanosci. Nanotechnol. · 2006 · 6 · 94810.1166/jnn.2006.133 ↗
15. Kulkarni · Nanoscale · 2012 · 4 · 577910.1039/c2nr31465g ↗
16. Contal · J. Phys. Chem. B · 2010 · 114 · 571810.1021/jp1010007 ↗
17. Wallace · Nanotechnology · 2009 · 20 · 04510110.1088/0957-4484/20/4/045101 ↗
18. Kapralov · Acs Nano · 2012 · 6 · 414710.1021/nn300626q ↗
19. Patra · J. Am. Chem. Soc. · 2011 · 133 · 614610.1021/ja2009778 ↗
20. Qiao · J. Am. Chem. Soc. · 2006 · 128 · 1365610.1021/ja063977y ↗
21. Paukner · Nanoscale · 2013 · 5 · 899210.1039/c3nr02068a ↗
22. Kulkarni · Phys. Chem. Chem. Phys. · 2011 · 13 · 300410.1039/C0CP01539C ↗
23. Z. Almsherqi , F.Margadant and Y.Deng , in Advances in Planar Lipid Bilayers and Liposomes , Elsevier , 2010 , vol. 12 , ch. 4, pp. 79–99
24. C. V. Kulkarni , in Advances in Planar Lipid Bilayers and Liposomes , ed. A. Iglic , Academic Press , 2010 , vol. 12 , ch. 9, pp. 237–272
25. Song · J. Am. Chem. Soc. · 2008 · 130 · 1260210.1021/ja8047464 ↗
26. Gustafsson · Langmuir · 1996 · 12 · 461110.1021/la960318y ↗
27. C. V. Kulkarni , in Encyclopaedia of Biophysics , ed. G. C. Roberts , Springer Varlag , 2012
28. Yaghmur · Adv. Colloid Interface Sci. · 2009 · 147–148 · 33310.1016/j.cis.2008.07.007 ↗
29. C. V. Kulkarni and O.Glatter , in Self-Assembled Supramolecular Architectures: Lyotropic Liquid Crystals , ed. N. Garti , John Wiley & Sons, Inc. , 2012 , ch. 6
30. Rizwan · Expert Opin. Drug Del. · 2010 · 7 · 113310.1517/17425247.2010.515584 ↗
31. Nguyen · J. Pharm. Pharmacol. · 2010 · 62 · 84410.1211/jpp.62.07.0005 ↗
32. Lee · Int. J. Pharm. · 2009 · 365 · 19010.1016/j.ijpharm.2008.08.022 ↗
33. Worthington · Trends Biotechnol. · 2013 · 31 · 17710.1016/j.tibtech.2012.12.006 ↗
34. Araoka · Nihon rinsho. Jpn. J. Clin. Med. · 2012 · 70 · 305
35. Mezzenga · Langmuir · 2005 · 21 · 332210.1021/la046964b ↗
36. Landau · Proc. Natl. Acad. Sci. U. S. A. · 1996 · 93 · 1453210.1073/pnas.93.25.14532 ↗
37. Pickering · J. Chem. Soc. · 1907 · 91 · 200110.1039/CT9079102001 ↗
38. Caffrey · Annu. Rev. Biophys. · 2009 · 38 · 2910.1146/annurev.biophys.050708.133655 ↗
39. Kulkarni · Soft Matter · 2010 · 6 · 433910.1039/c0sm00353k ↗
40. Bokobza · Express Polym. Lett. · 2012 · 6 · 60110.3144/expresspolymlett.2012.63 ↗
41. Douroumis · Int. J. Nanomed. · 2007 · 2 · 761
42. Zhao · Philos. Trans.: Math., Phys. Eng. Sci. · 2004 · 362 · 240710.1098/rsta.2004.1447 ↗
43. Bottini · Toxicol. Lett. · 2006 · 160 · 12110.1016/j.toxlet.2005.06.020 ↗
44. Wick · Toxicol. Lett. · 2007 · 168 · 12110.1016/j.toxlet.2006.08.019 ↗